MODEL 3000 AXYALOOP BIO-ABSORBABLE BONE ANCHOR

{0}------------------------------------------------ K051983 9'/3 # AUG 5 - 2005 ## 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS (Per 21 CFR 807.92) ## General Company Information - Axya Medical, Inc. Name: Howard Schrayer Contact: Regulatory Affairs Consultant - 100 Cummings Center Address: Suite 444C Beverly, MA 01915 - (978) 232 9997 Telephone: (978) 232 - 9998 Fax: - July 21, 2005 Date Prepared #### General Device Information | Product Name: | Model 3000 AxyaLoop™ Bio-Absorbable Bone Anchor | |-----------------|-----------------------------------------------------------------------------| | Classification: | "Biodegradable soft tissue fixation fastener"<br>Product code: MAI Class II | #### Predicate Devices Axya Model 5000 AxyaLoop™ Bio-Absorbable Bone Anchor [510(k) Number K041698] Arthrex Inc. BioFASTak™ Suture Anchor Model AR-1324B [501(k) Number K000506] #### Description The device is designed with a corkscrew style thread 3.0 mm in diameter, for use in a range of soft tissue to bone attachment procedures. The Axya Bone Anchor will be made available as a system together with a thread tap and a placement tool (driver). These accessories are the same types of instruments included in procedure sets for currently marketed bone anchor systems. Axya Medical believes that the accessory instruments are Class I Manual Surgical Instruments and are exempt from the premarket Notification regulations. The Axya Model 3000 Bio-Absorbable Bone Anchor is prethreaded with polypropylene monofilament, nylon, braided polyester, and braided polyethylene suture material. {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows handwritten text that appears to be a combination of letters and numbers. The text reads 'K051983' followed by '1 2/3'. The handwriting is somewhat stylized, with some characters slightly distorted or connected. The Model 3000 Bio-Absorbable Bone Anchor is designed for use in both standard open surgical procedures and in minimally invasive (arthroscopic) surgical procedures. ## Intended Use (Indications) The Axya Model 3000 AxyaLoop™ Bio-Absorbable Bone Anchor is indicated for securing suture to bone. This device is intended for use in the following applications: Shoulder: Rotator cuff, Bankart, and SLAP lesion repair, Biceps tenodesis, Acromio-Clavicular separation and Deltoid repair, Capsular shift and Capsulolabral reconstruction Foot/Ankle: Lateral and Medial stabilization, Achilles tendon and Metatarsal ligament repair, Hallux Valgus and Midfoot reconstruction Knee: Medial collateral and Lateral collateral ligament repair, Patellar tendon and Posterior oblique ligament repair, Iliotibial band tenodesis Hand/Wrist: Scapholunate ligament, Radial collateral ligament and Ulnar collateral ligament reconstruction Elbow: Biceps tendon reattachment, Tennis elbow repair, Ulnar and Radial collateral ligament reconstruction Pelvis: Bladder neck suspension for urinary incontinence due to urethral hypermobility or intrinsic sphincter deficiency in females ### Substantial Equivalence This submission supports the position that the Axya Model 3000 Bio-Absorbable Bone Anchor is substantially equivalent to a number of previously cleared devices, including the Axya Model 5000 AxyaLoop Bio-Absorbable Bone Anchor [510(k) Number K041698] and the Arthrex Inc. BioFASTak Model AR-1324B Suture Anchor. The 510(k) Notice contains summaries of in vitro studies that were conducted to evaluate the anchor pull-out strength as specified in the FDA Guidance Document for Testing Bone Anchor Devices (dated April 20, 1996). The data presented demonstrate that the anchor pull-out force of the Axya Model 3000 AxyaLoop Bio-Absorbable Bone Anchor compared favorably with the predicate device of similar corkscrew geometry. The failure mode observed for the Axya anchor was predominately the same as that of the predicate anchor. The single-patient-use components of the bone anchor system are provided sterile. The suture material and bone anchors are sterilized using a process equivalent to the process used by the original suture manufacturer. {2}------------------------------------------------ K051983 p³/₃ ### Conclusions Axya Medical, Inc. believes that the information provided establishes that similar legally Axya Mculoar, me. bonovoo that the me clinical applications as the Axya Model 3000 Biomanotod have boom and . The materials from which the Axya device is fabricated have an Absorbable Bono I theneve the nical applications, and devices produced by Axya have been tested in accordance with applicable FDA guidelines. {3}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES AUG 5 - 2005 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Howard L. Schrayer Regulatory Affairs Consultant . . . . Axya Medical, Inc. 100 Cummings Center, Suite 444C Beverly, Massachusetts 01915 ↓ Re: K051983 K051983 Trade/Device Name: Model 3000 AxyaLoop™ Bio-Absorbable Bone Anchor Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: II Product Code: MAI Dated: July 21, 2005 Received: July 25, 2005 Dear Mr. Schrayer: We have reviewed your Section 510(k) premarket notification of intent to market the indication We have reviewed your Section 510(x) prematics is substantially equivalent (for the indications referenced above and have determined the devices marketed in interstate referenced above and nave determined the arreed predicate devices marketed in interstate for use stated in the enclosure) to tegally manced produced Device Amendments, or to commerce prior to May 28, 1976, the enactment at the Federal Food. Drug commerce prior to May 28, 1970, the chaculters with the provisions of the Federal Food, Drug, devices that have been reclassified in accordance with as proval application (PMA). and Cosmetic Act (Act) that do not require approval assesses approvisions of the Act . The and Cosmetic Act (Act) that to not require appro the general controls provisions of the Act. The You may, therefore, market the device, sucject to use going mishranding and general controls provisions of the Act merade requirement of the security misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (see aove) mio entire) and in trepulations affecting your device can may be subject to such additional controls. Existing major regulations FDA may be subject to such additional controls: Extroing may or 898 In addition, FDA may be found in the Code of Federal Regulations, Title 21, Parts 800 Register be found in the Couc of Pederal Tegarations) publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that FDA s issualice of a substitution with other requirements of the Act that FDA has made a determination that your device Forel agemes You must that FDA has made a determination that your are res or other Federal agencies. You must or any Federal statutes and regulations administered by other not listing or any Federal statures and regulations administration and listing (21 comply with all the Act's requirements, including, but not of seguirements as set comply with all the Act s requirements, menames and starting practice requirements as set CFR Part 807); labeling (21 CFR Part 801); great 800); and if enplicable, the electr CFR Part 807); labeling (21 CFR 1 at 801); good manata 820); and if applicable, the electronic forth in the quality systems (QS) regulation (21 CFR 1000-1050 forth in the quality systems (QS) regulation (Sections 531-542 of the Act); 21 CFR 1000-1050. product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000- {4}------------------------------------------------ # Page 2 - Mr. Howard L. Schrayer This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will anow you to begin markstill equivalence of your device to a legally premarket notification. The FDA finding of substantial equivales and thus, normits vour prematket notification. The PDA miding of substanted by and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please extitled If you desire specific advice for your car (240) 276-__. Also, please note the regulation entitled, comact the Office of Complanoo at (210) 276 - 17 (21CFR Part 807.97). You may obtain "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtai "Misbranding by reference to premance nouthead.org the Act from the Division of Small other general information on your responsibilities under the Act from the 1900 C28, 000 other general information on your responsion.iss and of its toll-fire number (800) 638-2041 or Manufacturers, International and Consumer Plastianse and Constitutions try/support/index.html. Sincerely yours, Stipt Rlrodu Mark N. Melkerson Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ ### INDICATIONS FOR USE 510(k) Number (if known): Device Name: Axya, Model 3000 AxyaLoop™ Bio-Absorbable Bone Anchor Indications For Use: The Axya Model 3000 AxyaLoop™ Bio-Absorbable Bone Anchor is indicated for securing The Axya Model 5000 / kyazoop - dee in the following applications: Shoulder: Rotator cuff, Bankart, and SLAP lesion repair, Biceps tenodesis, Acromo-Shoulder: Rotator cun, Dankart, and SEAR shift and Capsulolabral reconstruction Foot/Ankle: Lateral and Medial stabilization, Achilles tendon and Metatarsal ligament repair, Hallux Valgus and Midfoot reconstruction Knee: Medial collateral and Lateral collateral ligament repair, Patellar tendon and Posterior oblique ligament repair, Iliotibial band tenodesis Hand/Wrist: Scapholunate ligament, Radial collateral ligament and Ulnar collateral ligament reconstruction Elbow: Biceps tendon reattachment, Tennis elbow repair, Ulnar and Radial collateral ligament reconstruction Pelvis: Bladder neck suspension for urinary incontinence due to urethral hypermobility or intrinsic sphincter deficiency in females Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use_ (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Division of General, Restorative, and Neurological Devices 510(k) Number K051983